Singapore’s Biofourmis raises $1m to bring computing power, AI to manage health-tech data

Biofourmis website homepage

Singapore-based Biofourmis, which claims to be the world’s first personalised physiological data analytics firm, has closed a US$ 1 million round, that was led by South African healthcare professional services provider SpesNet and Eden Strategy.  The round also saw participation from other angel investors in the healthcare space.

Continue reading this story with a subscription to DealStreetAsia.

Subscribe

Should your colleagues be reading this article too? Contact us for corporate subscriptions at subs@dealstreetasia.com.